October 23, 2015
A former CFR Pharmaceuticals SA board member has agreed to pay $13.2 million to settle U.S. Securities and Exchange Commission allegations that he traded on insider information in Abbott Laboratories' $3.3 billion takeover of CFR, according to a settlement agreement filed in New York federal court Friday.
December 22, 2014
The U.S. Securities and Exchange Commission on Monday hit two Chilean businessmen, including an ex-board member of CFR Pharmaceuticals SA, with a New York federal suit alleging they made $10.6 million by trading on insider information in Abbott Laboratories' $3.3 billion takeover of CFR.